Search

everythinglearnresearchcommunity

for

Search:↓

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Interleukin‐1 α reduces androgen receptor levels and increases certain cytokines in human scalp cells.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

No clear link between androgen receptor variation and hair loss, but more research needed.

LH and hCG reduce certain protein levels in women's skin.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Longer CAG repeats in gene linked to more severe hair loss in females.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Diphenyl ethers can potentially reduce excess oil production when applied on the skin, helping treat conditions like acne.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

No significant link between CAG repeat numbers and female pattern hair loss in Han Chinese population.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Nuclear AR levels give better insight into hormone effects in skin conditions.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

Clascoterone may be an effective topical treatment for hair loss.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Parsley contains compounds that might be good for treating hair loss.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.

No clear link between specific gene and hair loss in Mexican brothers.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.